364 related articles for article (PubMed ID: 25794555)
21. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
22. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
Farrell HE; Bruce K; Stevenson PG
J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
Revello MG; Gerna G
Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
[TBL] [Abstract][Full Text] [Related]
24. The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.
Liu J; Jardetzky TS; Chin AL; Johnson DC; Vanarsdall AL
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111564
[TBL] [Abstract][Full Text] [Related]
25. The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL.
Caló S; Cortese M; Ciferri C; Bruno L; Gerrein R; Benucci B; Monda G; Gentile M; Kessler T; Uematsu Y; Maione D; Lilja AE; Carfí A; Merola M
J Virol; 2016 May; 90(10):4926-38. PubMed ID: 26937030
[TBL] [Abstract][Full Text] [Related]
26. Development of novel vaccines against human cytomegalovirus.
Cui X; Snapper CM
Hum Vaccin Immunother; 2019; 15(11):2673-2683. PubMed ID: 31017831
[TBL] [Abstract][Full Text] [Related]
27. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
Gerna G; Lilleri D
New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
[TBL] [Abstract][Full Text] [Related]
28. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
Webster H; Valencia S; Kumar A; Chan C; Dennis M; Roark H; Woods A; John S; Carfi A; Permar SR
Vaccine; 2021 Sep; 39(38):5358-5367. PubMed ID: 34393017
[TBL] [Abstract][Full Text] [Related]
29. Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.
Mahmud J; Miller MJ; Altman AM; Chan GC
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493823
[TBL] [Abstract][Full Text] [Related]
30. Vaccination against a virus-encoded cytokine significantly restricts viral challenge.
Eberhardt MK; Deshpande A; Chang WL; Barthold SW; Walter MR; Barry PA
J Virol; 2013 Nov; 87(21):11323-31. PubMed ID: 23946461
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
Choi KY; El-Hamdi NS; McGregor A
Vaccine; 2020 Feb; 38(10):2340-2349. PubMed ID: 32008881
[TBL] [Abstract][Full Text] [Related]
32. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity.
Cui X; Cao Z; Wang S; Flora M; Adler SP; McVoy MA; Snapper CM
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261659
[TBL] [Abstract][Full Text] [Related]
33. HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
Vanarsdall AL; Chin AL; Liu J; Jardetzky TS; Mudd JO; Orloff SL; Streblow D; Mussi-Pinhata MM; Yamamoto AY; Duarte G; Britt WJ; Johnson DC
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3728-3733. PubMed ID: 30733288
[TBL] [Abstract][Full Text] [Related]
34. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE; Mason PW
Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
[TBL] [Abstract][Full Text] [Related]
35. Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
Eberhardt MK; Deshpande A; Fike J; Short R; Schmidt KA; Blozis SA; Walter MR; Barry PA
J Virol; 2016 Nov; 90(21):9920-9930. PubMed ID: 27558431
[TBL] [Abstract][Full Text] [Related]
36. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors.
Ryckman BJ; Chase MC; Johnson DC
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14118-23. PubMed ID: 18768787
[TBL] [Abstract][Full Text] [Related]
37. Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
Xia L; Su R; An Z; Fu TM; Luo W
Hum Vaccin Immunother; 2018 Feb; 14(2):292-303. PubMed ID: 29053403
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells.
Ryckman BJ; Rainish BL; Chase MC; Borton JA; Nelson JA; Jarvis MA; Johnson DC
J Virol; 2008 Jan; 82(1):60-70. PubMed ID: 17942555
[TBL] [Abstract][Full Text] [Related]
39. Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2014; 1119():311-48. PubMed ID: 24639230
[TBL] [Abstract][Full Text] [Related]
40. Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes.
Ciferri C; Chandramouli S; Donnarumma D; Nikitin PA; Cianfrocco MA; Gerrein R; Feire AL; Barnett SW; Lilja AE; Rappuoli R; Norais N; Settembre EC; Carfi A
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1767-72. PubMed ID: 25624487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
